Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 28, 2011CancerOpen Access

Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome

View Full Paper
Ask AI
Bookmark
Share

Authors

YGYun Yun GongUniversity of Science and Technology of ChinaLHLei HuoHarbin Institute of TechnologyPLPing LiuJinan Maternity And Care Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gong et al. (2011) studied this question.

synapsesocial.com/papers/6aa50f791492f90b230a57fahttps://doi.org/10.1002/cncr.26179
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein2002 · 1,634 citations
  2. 2Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma2005 · 243 citations
  3. 3Increased Expression of the Polycomb Group Gene, EZH2, in Transitional Cell Carcinoma of the Bladder2005 · 193 citations
  4. 4MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β2010 · 255 citations
  5. 5Integration of Estrogen and Wnt Signaling Circuits by the Polycomb Group Protein EZH2 in Breast Cancer Cells2007 · 343 citations